Clearside Biomedical (CLSD) Stock Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CLSD Stock Alerts $1.34 +0.08 (+6.35%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Clearside Biomedical Stock Price Performance5 Day Performance-0.14%1 Month Performance-22.59%3 Month Performance+6.36%6 Month Performance+92.38%Year-To-Date Performance+11.81%1 Year Performance+24.00% Receive CLSD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clearside Biomedical and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> CLSD Stock Chart for Friday, April, 26, 2024 CLSD Chart by TradingView Clearside Biomedical Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024$1.34$1.26-5.97%$1.34$1.26135,231 shs$94.15 million04/24/2024$1.37$1.34-2.19%$1.45$1.29201,248 shs$100.13 million04/23/2024$1.41$1.37-2.84%$1.47$1.35232,156 shs$102.37 million04/22/2024$1.31$1.41+7.63%$1.46$1.29299,006 shs$105.36 million04/19/2024$1.32$1.31-0.76%$1.45$1.26228,016 shs$97.88 million04/18/2024$1.26$1.32+4.76%$1.39$1.24329,091 shs$98.63 million Get the Latest News and Ratings for CLSD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clearside Biomedical and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$1.15$1.26+9.57%$1.27$1.11329,243 shs$94.15 million04/16/2024$1.29$1.15-10.85%$1.27$1.15331,932 shs$85.93 million04/15/2024$1.25$1.29+3.20%$1.30$1.21184,217 shs$96.39 million04/12/2024$1.30$1.25-3.85%$1.34$1.24372,476 shs$93.40 million04/11/2024$1.24$1.30+4.84%$1.34$1.23181,624 shs$97.14 million04/10/2024$1.29$1.24-3.88%$1.32$1.23183,201 shs$92.65 million04/09/2024$1.29$1.29$1.35$1.20307,019 shs$96.39 million04/08/2024$1.30$1.29-0.77%$1.37$1.22304,784 shs$96.39 million04/05/2024$1.33$1.30-2.26%$1.40$1.28518,859 shs$97.14 million04/04/2024$1.43$1.33-6.99%$1.43$1.33144,309 shs$99.38 million04/03/2024$1.40$1.43+2.14%$1.45$1.31189,891 shs$106.85 million04/02/2024$1.58$1.40-11.39%$1.63$1.23720,336 shs$104.61 million04/01/2024$1.53$1.58+3.27%$1.61$1.50232,986 shs$118.06 million03/29/2024$1.53$1.53$1.73$1.50442,691 shs$114.32 million03/28/2024$1.67$1.53-8.38%$1.72$1.50442,364 shs$114.32 million03/27/2024$1.69$1.67-1.18%$1.76$1.56520,735 shs$124.78 million03/26/2024$1.73$1.69-2.31%$1.76$1.63203,051 shs$126.28 million03/25/2024$1.71$1.73+1.17%$1.78$1.68177,614 shs$129.27 million03/22/2024$1.80$1.71-5.00%$1.80$1.67239,738 shs$127.77 million03/21/2024$1.63$1.80+10.43%$1.80$1.63571,105 shs$134.50 million03/20/2024$1.63$1.63$1.68$1.55592,626 shs$121.79 million03/19/2024$1.56$1.63+4.49%$1.67$1.52368,734 shs$121.79 million03/18/2024$1.71$1.56-8.77%$1.78$1.49858,029 shs$116.56 million03/15/2024$1.73$1.71-1.16%$1.83$1.69552,152 shs$127.77 million03/14/2024$1.63$1.73+6.13%$1.93$1.61852,859 shs$110.05 million03/13/2024$1.64$1.63-0.61%$1.91$1.63850,414 shs$103.68 million03/12/2024$2.02$1.64-18.81%$2.12$1.581.12 million shs$104.32 million03/11/2024$1.67$2.02+20.96%$2.07$1.641.28 million shs$128.49 million03/08/2024$1.67$1.67$1.87$1.66794,349 shs$106.23 million03/07/2024$1.51$1.67+10.60%$1.74$1.572.98 million shs$106.23 million03/06/2024$1.39$1.51+8.63%$1.65$1.351.67 million shs$96.05 million03/05/2024$1.39$1.39$1.40$1.3574,857 shs$88.42 million03/04/2024$1.39$1.39$1.40$1.33135,675 shs$88.42 million03/01/2024$1.40$1.39-0.71%$1.43$1.3571,765 shs$88.42 millionProtect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late.02/29/2024$1.41$1.40-0.71%$1.43$1.36132,585 shs$89.05 million02/28/2024$1.40$1.41+1.08%$1.44$1.36327,197 shs$89.69 million02/27/2024$1.34$1.40+4.10%$1.44$1.30377,271 shs$88.74 million02/26/2024$1.36$1.34-1.47%$1.37$1.3093,091 shs$85.24 million02/23/2024$1.33$1.36+2.26%$1.37$1.28148,568 shs$86.51 million02/22/2024$1.30$1.33+2.31%$1.33$1.28125,774 shs$84.60 million02/21/2024$1.29$1.30+0.78%$1.34$1.2181,894 shs$82.69 million02/20/2024$1.25$1.29+3.20%$1.30$1.20123,372 shs$82.06 million02/19/2024$1.25$1.25$1.28$1.20101,600 shs$79.51 million02/16/2024$1.22$1.25+2.46%$1.28$1.2096,367 shs$79.51 million02/15/2024$1.23$1.22-0.81%$1.29$1.17163,465 shs$77.60 million02/14/2024$1.30$1.23-5.38%$1.40$1.21211,794 shs$78.24 million02/13/2024$1.38$1.30-5.80%$1.40$1.2089,295 shs$82.69 million02/12/2024$1.42$1.38-2.82%$1.43$1.32217,213 shs$86.12 million02/09/2024$1.38$1.42+2.90%$1.46$1.37225,156 shs$88.62 million02/08/2024$1.38$1.38$1.41$1.35130,374 shs$86.13 million02/07/2024$1.41$1.38-2.13%$1.41$1.3579,470 shs$88.00 million02/06/2024$1.39$1.41+1.44%$1.43$1.3752,958 shs$88.00 million02/05/2024$1.37$1.39+1.46%$1.42$1.3554,526 shs$86.75 million02/02/2024$1.33$1.37+3.01%$1.38$1.3181,024 shs$85.50 million02/01/2024$1.25$1.33+6.40%$1.33$1.2558,723 shs$83.01 million01/31/2024$1.34$1.25-6.72%$1.35$1.2486,279 shs$78.01 million01/30/2024$1.30$1.34+3.08%$1.34$1.2981,475 shs$83.63 million01/29/2024$1.23$1.30+5.69%$1.30$1.2079,870 shs$81.13 million01/26/2024$1.21$1.23+1.65%$1.26$1.10164,980 shs$76.76 million01/25/2024$1.23$1.21-1.63%$1.38$1.14244,109 shs$75.52 million Related Companies: Barinthus Biotherapeutics Stock Chart Eliem Therapeutics Stock Chart Cellectar Biosciences Stock Chart FibroGen Stock Chart Vaccitech Stock Chart Anixa Biosciences Stock Chart IO Biotech Stock Chart Cyteir Therapeutics Stock Chart OptiNose Stock Chart Oramed Pharmaceuticals Stock Chart Receive CLSD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Clearside Biomedical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CLSD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearside Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.